Barclays' costly Protium exit leaves sour taste
The UK bank has reversed a deal that limited its exposure to market fluctuations on $12.3 bln of toxic assets. But to do so it has paid $83 mln to a group of exemployees for just 18 months' work. The exit revives questions about why Barclays ever agreed to the transaction.
This content is for Subscribers only
To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.